AstraZeneca PLC AZN-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 8:25 AM GMT
10,748.00quote price arrow up+6.00 (+0.06%)
52 week range
9,443.00 - 12,392.00
Loading...
  • Open10,756.00
  • Day High10,780.00
  • Day Low10,736.00
  • Prev Close10,742.00
  • 52 Week High12,392.00
  • 52 Week High Date04/18/23
  • 52 Week Low9,443.00
  • 52 Week Low Date02/13/24

Key Stats

  • Market Cap205,167.95M
  • Shares Out1,550.21M
  • 10 Day Average Volume2.37M
  • Dividend227.80
  • Dividend Yield2.12%
  • Beta0.64
  • YTD % Change1.43

KEY STATS

  • Open10,756.00
  • Day High10,780.00
  • Day Low10,736.00
  • Prev Close10,742.00
  • 52 Week High12,392.00
  • 52 Week High Date04/18/23
  • 52 Week Low9,443.00
  • 52 Week Low Date02/13/24
  • Market Cap205,167.95M
  • Shares Out1,550.21M
  • 10 Day Average Volume2.37M
  • Dividend227.80
  • Dividend Yield2.12%
  • Beta0.64
  • YTD % Change1.43

RATIOS/PROFITABILITY

  • EPS (TTM)301.65
  • P/E (TTM)35.63
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/22/2024
  • Div Amount156.00
  • Split Date-
  • Split Factor-

Profile

MORE
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology. Its pipeline forms a portfolio of investigational therapies in various stages of clinical development and includes the Alexion Rare Disease portfolio comprising approximately 178 projects....
Michel Demare
Non-Executive Independent Chairman of the Board
Pascal Soriot
Chief Executive Officer, Executive Director
Aradhana Sarin M.D.
Chief Financial Officer, Executive Director
Ruud Dobber Ph.D.
Executive Vice President - BioPharmaceuticals Business Unit
Susan Galbraith
Executive Vice President - Oncology and Research and Development
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom